Turning science into business: An optimised alternative to antibodies
Drug Discovery World
APRIL 3, 2023
Addressing this need in the market has allowed us penetration to work with 75% of the top twenty pharma companies. Equally, the controlled chemistry of Optimer offers the ability for precise aptamer-drug ratios, with conjugation at specific sites on the molecule to simplify therapeutic manufacture.
Let's personalize your content